We mentioned here that a reduction in Cx43 expression can reduce cell sensitivity to cisplatin and oxaliplatin; however, a reduction in Cx43 expression can increase the sensitivity of malignant glioma cells to TMZ [207]. Here, GJA1 is linked to malignant glioma.